Arun Rajan is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Rajan is rated as an Elite provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Thymic Epithelial Tumor, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).

Corey Carter is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Carter is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Thymic Epithelial Tumor.

James Gulley is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Gulley is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Prostate Cancer, Olfactory Neuroblastoma, Chordoma, Urothelial Cancer, and Orchiectomy.

Jonathan Lischalk is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Lischalk is rated as a Distinguished provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Prostate Cancer, Pleuropulmonary Blastoma, Thymic Epithelial Tumor, and Lung Cancer.

Nyen Chong is a Thoracic Surgeon in Silver Spring, Maryland. Dr. Chong is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Fibrosing Mediastinitis, Thymectomy, and Endoscopy. Dr. Chong is currently accepting new patients.

Philip Corcoran is a Cardiologist and a Thoracic Surgeon in Silver Spring, Maryland. Dr. Corcoran is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Collapsed Lung, Fibrosing Mediastinitis, Pleurisy, Heart Transplant, and Gastrostomy. Dr. Corcoran is currently accepting new patients.

Nobuyuki Takahashi is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Takahashi is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Neuroendocrine Tumor, Islet Cell Transplantation, and Pancreatectomy.

Christopher Eger is a Thoracic Surgeon in Washington, Washington, D.c.. Dr. Eger is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Gangrene, Collapsed Lung, Pleuropulmonary Blastoma, Gastrostomy, and Thymectomy.

Edward Chan is a Thoracic Surgeon in Washington, Washington, D.c.. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Heart Tumor, Hiatal Hernia, Diaphragmatic Hernia, Endoscopy, and Lung Transplant.

Ann Hwalek is a Thoracic Surgeon in Washington, Washington, D.c.. Dr. Hwalek is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. Her top areas of expertise are Thoracic Outlet Syndrome, Thymic Epithelial Tumor, Lung Cancer, Pancreaticoduodenectomy, and Lung Transplant.

Dennis Priebat is a Hematologist Oncology specialist and an Oncologist in Washington, Washington, D.c.. Dr. Priebat is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Mesenchymoma, and Rhabdomyosarcoma Embryonal.

Pamela Randolph-Jackson is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Randolph-Jackson is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. Her top areas of expertise are Posterior Fossa Tumor, Anal Cancer, Small Cell Lung Cancer (SCLC), and Lung Cancer.

Adedamola Omogbehin is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Omogbehin is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Adenoid Cystic Carcinoma, Anal Cancer, Endometrial Cancer, and Intraductal Papilloma.

Chul Kim is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Kim is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Non-Small Cell Lung Cancer (NSCLC). Dr. Kim is currently accepting new patients.

Stephen Liu is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Liu is currently accepting new patients.

Deepa Subramaniam is an Oncologist in Washington, Washington, D.c.. Dr. Subramaniam is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Keith Mortman is a Thoracic Surgeon in Washington, Washington, D.c.. Dr. Mortman is rated as an Advanced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Lung Nodules, Thymectomy, and Endoscopy.

Stephen R. Broderick, M.D., MPHS, is an assistant professor of surgery at Johns Hopkins University School of Medicine and a thoracic surgeon, part of a multidisciplinary team treating lung cancer patients in the Johns Hopkins Kimmel Cancer Center. Listen to Dr. Broderick's Cancer Matters podcast episode to learn more about his work. Dr. Broderick's primary clinical focus is at Sibley Memorial Hospital, in Washington, D.C. He also practices at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore, Maryland. Dr. Broderick has a clinical expertise in surgical treatment of lung cancer, esophageal cancer and other thoracic malignancies, as well as benign thoracic conditions. This includes achalasia, bronchoscopy, chest wall reconstruction and tumors, lung nodules and paraesophageal hernias. He has a clinical interest in minimally invasive surgery for lung cancer and the coordinated delivery of multidisciplinary care for thoracic oncology patients. Before joining Johns Hopkins, Dr. Broderick was a thoracic surgeon at St Luke’s Hospital, where he served as the medical director of the cardiothoracic intensive care unit and a member of the oncology steering committee. He also served as an instructor of surgery at Washington University School of Medicine. Dr. Broderick received his medical degree from Georgetown University School of Medicine in 2003 and he completed his internship and residency training in general surgery at New York-Presbyterian Hospital. He studied the molecular biology of lung cancer as a research fellow at Memorial Sloan Kettering Cancer Center, where he received the Chairman's Award for outstanding contributions to the basic science research fellowship. Dr. Broderick also completed a fellowship in thoracic surgery at Washington University School of Medicine in 2012 and earned a Masters in Population Health Science from Washington University School of Medicine in 2014. Dr. Broderick is a member of the American College of Chest Physicians, The Society of Thoracic Surgeons and the American Society of Clinical Oncology. Dr. Broderick’s research interests are focused on improving outcomes for lung cancer patients. He is particularly interested in studying how various treatments for early-stage lung cancer impact patients’ quality of life. Dr. Broderick has contributed to numerous publications and is a reviewer for the Journal of Cardiovascular and Thoracic Surgery, as well as Annals of Thoracic Surgery. Dr. Broderick is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Tubal Ligation, and Lung Transplant.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Experienced provider by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer.